Day Zero Diagnostics
![Day Zero team]()
Harvard Innovation Labs
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
Awards & Affiliations
In The Press View all
-
bioMieux acquires assets of Day Zero Diagnostics
-
Day Zero shares AI-based approach to antimicrobial susceptibility testing
Lab Pulse
-
AI could help speed antibiotic selection for sepsis
Healio
-
Day Zero Diagnostics inks new partnership for bloodstream infection diagnostics
Mass Device
-
Day Zero Diagnostics Closes $16M Financing Round
360 Dx
